Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
OPERATING ACTIVITIES:
Net income (loss)	$ (255)	$ 538
Adjustments to reconcile to net cash provided (used) by operating activities:
Depreciation and amortization	859	840
Provision (benefit) for deferred income taxes	(59)	182
Equity (earnings) losses	(130)	(167)
Distributions from unconsolidated affiliates	323	327
Gain on disposition of equity-method investments (Note 5)	0	(122)	[1]
Impairment of goodwill (Note 12)	187	0
Impairment of equity-method investments (Note 12)	938	72
Impairment of certain assets (Note 12)	0	76
Amortization of stock-based awards	24	30
Cash provided (used) by changes in current assets and liabilities:
Accounts receivable	85	149
Inventories	(9)	4
Other current assets and deferred charges	(13)	(16)
Accounts payable	236	(98)
Accrued liabilities	(236)	70
Other, including changes in noncurrent assets and liabilities	(20)	(41)
Net cash provided (used) by operating activities	1,930	1,844
FINANCING ACTIVITIES:
Proceeds from (payments of) commercial paper – net	0	(4)
Proceeds from long-term debt	3,896	720
Payments of long-term debt	(3,226)	(868)
Proceeds from issuance of common stock	6	6
Common dividends paid	(971)	(921)
Dividends and distributions paid to noncontrolling interests	(98)	(68)
Contributions from noncontrolling interests	4	32
Payments for debt issuance costs	(17)	0
Other – net	(10)	(9)
Net cash provided (used) by financing activities	(416)	218
INVESTING ACTIVITIES:
Capital expenditures (1)	(613)	(919)
Dispositions - net	(16)	(15)
Contributions in aid of construction	19	18
Purchases of businesses, net of cash acquired (Note 2)	0	(727)
Proceeds from dispositions of equity-method investments (Note 5)	0	485
Purchases of and contributions to equity-method investments	(66)	(242)
Other – net	6	(24)
Net cash provided (used) by investing activities	(670)	(1,424)
Increase (decrease) in cash and cash equivalents	844	638
Cash and cash equivalents at beginning of year	289	168
Cash and cash equivalents at end of period	1,133	806
(1) Increases to property, plant, and equipment	(581)	(977)
Changes in related accounts payable and accrued liabilities	(32)	58
Capital expenditures (1)	(613)	(919)
Northeast JV [Member]
FINANCING ACTIVITIES:
Contributions from noncontrolling interests	$ 0	$ 1,330

[1] In April 2019, we sold our 50 percent equity-method interest in Jackalope for $485 million in cash, resulting in a gain on the disposition of $122 million.